Trial intelligence / Profile preview

Effect of acetazolamide on prevention of cerebrospinal fluid leakage after spinal surgery

IRCT201501178612N2Phase 3Completed

Sponsor
Pharmaceutical Care Department, Shariati Hospital
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetazolamide in dural defect, sponsored by Pharmaceutical Care Department, Shariati Hospital. Started Sep 2014; status: completed.

02

Drugs

acetazolamide
03

Conditions

dural defect

Beyond the preview

Go deeper on IRCT201501178612N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201501178612N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call